After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...

Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.

PARP inhibitors reshaped oncology when they first reached patients some 10 years ago, but they represent just one entry point into a much larger and more intricate biological network.

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate ...

IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 June 23, 2026 12:30 PM EDTCompany ParticipantsShaun Bagai - ...

Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...

Microsoft Threat Intelligence identified an active multi-stage intrusion campaign targeting hospitality organizations in ...

The nutritional epidemiologists and other scholars who have led this push in public health are out to challenge an entire ...

Perioperative anemia and red blood cell transfusions are important risk factors for morbidity and mortality in cardiac ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...

A journal editor decided to retract and remove a bad study by an antivaxxer named Neil Z. Miller. RFK Jr. publicly demanded ...